These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35768027)

  • 41. Radiotherapy and surgery for high-risk localized prostate cancer: a UK questionnaire survey of urologists and clinical oncologists.
    Gnanapragasam VJ; Persad R; Payne HA
    BJU Int; 2012 Sep; 110(5):608-12. PubMed ID: 22765394
    [No Abstract]   [Full Text] [Related]  

  • 42. Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients.
    Xu J; Bock C; Janisse J; Schwartz KL; Triest J; Cher ML; Goodman M
    Urology; 2021 Sep; 155():83-90. PubMed ID: 33482128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formation of combined urology and radiation oncology practices: objective data from radiation oncologists for rationale.
    Schilling PJ
    Am J Clin Oncol; 2011 Jun; 34(3):289-91. PubMed ID: 20805740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
    Philippou Y; Raja H; Gnanapragasam VJ
    BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey.
    Puneet K; Tilburt JC; Volk RJ; Bennett CL; Qureshi Z; Gershman B; Sedlacek HM; Kim SP
    Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13301. PubMed ID: 33112008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
    Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
    JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Re: variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
    Penson DF
    J Urol; 2014 Mar; 191(3):658. PubMed ID: 24522036
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Albertsen PC; Albertsen PC
    J Urol; 2001 Feb; 165(2):731-2. PubMed ID: 11233050
    [No Abstract]   [Full Text] [Related]  

  • 50. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
    Scherr KA; Fagerlin A; Hofer T; Scherer LD; Holmes-Rovner M; Williamson LD; Kahn VC; Montgomery JS; Greene KL; Zhang B; Ubel PA
    Med Decis Making; 2017 Jan; 37(1):56-69. PubMed ID: 27510740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urologists' Current Practices in Screening and Treating Men With a Family History of Prostate Cancer.
    Rudichuk L; Vogel KJ; Wang CH; Helfand BT; Selkirk CG
    Urology; 2017 Jan; 99():180-185. PubMed ID: 27645528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists' recommendations for active treatment or active surveillance: a randomized clinical utility trial.
    Peabody JW; DeMaria LM; Tamondong-Lachica D; Florentino J; Czarina Acelajado M; Ouenes O; Richie JP; Burgon T
    BMC Urol; 2017 Jul; 17(1):51. PubMed ID: 28673277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation.
    Wallis CJD; Morton G; Herschorn S; Kodama RT; Kulkarni GS; Appu S; Shayegan B; Buckley R; Grabowski A; Narod SA; Nam RK
    Br J Cancer; 2018 May; 118(10):1399-1405. PubMed ID: 29593338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate Cancer.
    Swami U; Hong A; El-Chaar NN; Ramaswamy K; Diessner BJ; Blauer-Peterson CJ; Sandin R; Nimke D; Agarwal N
    J Urol; 2023 Jun; 209(6):1120-1131. PubMed ID: 36789668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating the Current Place of Radiotherapy as Treatment Option for Patients With Muscle Invasive Bladder Cancer in Belgium.
    Fonteyne V; Rammant E; Ost P; Lievens Y; De Troyer B; Rottey S; De Meerleer G; De Maeseneer D; De Ridder D; Decaestecker K
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1159-e1169. PubMed ID: 30190222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coordination of breast cancer care between radiation oncologists and surgeons: a survey study.
    Jagsi R; Abrahamse P; Morrow M; Hamilton AS; Graff JJ; Katz SJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2072-8. PubMed ID: 21477932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists.
    Hamelinck VC; Stiggelbout AM; van de Velde CJH; Liefers GJ; Bastiaannet E
    Eur J Surg Oncol; 2017 Jul; 43(7):1288-1296. PubMed ID: 28258786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of minimally invasive prostatectomy on practice patterns of American urologists.
    Oberlin DT; Flum AS; Lai JD; Meeks JJ
    Urol Oncol; 2016 Jun; 34(6):255.e1-5. PubMed ID: 26935867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding Active Surveillance for Prostate Cancer.
    Lai LY; Shahinian VB; Oerline MK; Kaufman SR; Skolarus TA; Caram MEV; Hollenbeck BK
    JCO Oncol Pract; 2021 Nov; 17(11):e1678-e1687. PubMed ID: 33830822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical oncologists favour radical radiotherapy for localized prostate cancer: a questionnaire survey.
    Hanna CL; Mason MD; Donovan JL; Barber JP
    BJU Int; 2002 Oct; 90(6):558-60. PubMed ID: 12230617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.